Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page .
HC Wainwright & Co. analyst Swayampakula Ramakanth upgraded Innate Pharma S.A. (NASDAQ: IPHA ) from Neutral to Buy and announced a $5 price target. Innate Pharma shares closed at $2.09 on Tuesday. See how other analysts view this stock . Baird analyst Eric Coldwell upgraded IQVIA Holdings Inc. (NYSE: IQV ) from Neutral to Outperform and raised the price target from $224 to $258. IQVIA shares closed at $218.13 on Tuesday. See how other analysts view this stock . Jefferies analyst Matthew Taylor upgraded Edwards Lifesciences Corporation (NYSE: EW ) from Hold to Buy and raised the price target from $80 to $98. Edwards Lifesciences shares closed at $82.19 on Tuesday. See how other analysts view this stock . Keybanc analyst John Vinh upgraded Skyworks Solutions, Inc. (NASDAQ: SWKS ) from Sector Weight to Overweight and announced a $105 price target. Skyworks Solutions closed at $80.26 on Tuesday. See how other analysts view this stock .Considering buying EW stock? Here’s what analysts think:
Read This Next:
Jim Cramer: This Stock’s ‘Hot As A Pistol,’ Sell Super Micro ComputerPhoto via Shutterstock
Loading... Loading... BIP Brookfield Infrastructure Partners LP $33.65 -2.89% Overview EW Edwards Lifesciences Corp $84.50 2.81% IPHA Innate Pharma SA $2.20 5.26% IQV IQVIA Holdings Inc $218.13 -% LRN Stride Inc $89.00 -42.0% SWKS Skyworks Solutions Inc $82.00 2.17% Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Add CommentPosted In: News Upgrades Pre-Market Outlook Markets Analyst Ratings Trading Ideas top upgrades